Manuel García-Goñi

Associate Professor of Applied Economics at Complutense University of Madrid. Manuel earned his Ph.D. in Economics and MA in Political Economy at Boston University, specialized in the fields of Health Economics and Industrial Organization. He has acted as Visiting Scholar at Columbia University, as Visiting Fellow at the Australian National University at Canberra, and as Visiting Professor at Universidade Nova de Lisboa, Universitatea de Vest din Timisoara, Universidade do Porto, and Universidad Carlos III de Madrid. Since 2004 Manuel has been Academic Secretary and Director of the Spanish Encounter of the Drug Industry that takes place annually at Universidad Internacional Menéndez Pelayo in Santander, Spain. Between 2006 and 2012, he was a member of the Boards of Directors at the Spanish Health Economics Association, and the Chair of the Scientific Committee for the Spanish Health Economics Conference in 2012.

Manuel has published in peer reviewed economic journals such as Value in Health, Health Economics, Health Policy, Research Policy, European Journal of Health Economics, International Journal for Equity in Health, PLOS ONE, or Ageing & Society, among others. His research has been funded by institutions such as the European Commission, the Centers for Medicare & Medicaid Services (United States), the Institute for Fiscal Studies (Spain), or the Ramon Areces Foundation (Spain).

• Baji, P., García-Goñi, M., Gulacsi, L., Mentzakis, E., and Paolucci, F. (2015). Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries. European Journal of Health Economics. Forthcoming.
• García-Goñi, M., Nuño-Solinís, R., Orueta, J.F., and Paolucci, F. (2015). Is utilisation of health services for HIV patients equal by socioeconomic status? Evidence from the Basque Country. International Journal of Equity in Health, 14, 110.
• Paolucci, F., Sowa, P.M., García-Goñi, M., and Ergas, H. (2015). Mandatory aged care insurance: a case for Australia. Ageing and Society, 35(2), 231-245.
• Orueta, J.F., García-Álvarez, A., García-Goñi, M., Paolucci, F., and Nuño-Solinís, R. (2014). Prevalence and costs of multimorbidity by deprivation levels in the Basque Country. A population based study using health administrative databases. PLoS ONE 9(2), e89787.
• García-Goñi, M., Hernández-Quevedo, C., Nuño-Solinís, R., and Paolucci, F. (2012). Pathways towards chronic care-focused healthcare systems: evidence from Spain. Health Policy, 108, 236–245.

• Carreras, M., García-Goñi, M., et al. (2011). Estimates of costs related with population morbidity: changes in predictive power when overheads are allocated. European Journal of Health Economics, 12, 289–295.
• García-Goñi, M., Ibern, P., and Inoriza, J.M. (2009). Hybrid Risk Adjustment for Pharmaceutical Benefits. European Journal of Health Economics, 10, 299–308.
• García-Goñi, M. and Ibern, P. (2008). Predictability on drug expenditures: an application using morbidity data. Health Economics, 17(1), 119-126.
• Windrum, P. and García-Goñi, M. (2008). A neo-Schumpeterian model of health services innovation. Research Policy, 37(4), 649-672.
• García-Goñi, M., Maroto, A., and Rubalcaba, L. (2007). Innovation and worker motivation in public health. Health Policy, 84(2-3), 344-358.